CVS Health Co. (NYSE:CVS) Holdings Trimmed by RNC Capital Management LLC


Share on StockTwits

RNC Capital Management LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 4.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 688,304 shares of the pharmacy operator’s stock after selling 32,774 shares during the period. CVS Health accounts for 2.9% of RNC Capital Management LLC’s investment portfolio, making the stock its 7th biggest holding. RNC Capital Management LLC owned 0.05% of CVS Health worth $47,011,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CVS. CVA Family Office LLC grew its holdings in shares of CVS Health by 173.7% during the 3rd quarter. CVA Family Office LLC now owns 457 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 290 shares in the last quarter. Ellis Investment Partners LLC grew its holdings in shares of CVS Health by 47.0% during the 3rd quarter. Ellis Investment Partners LLC now owns 541 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 173 shares in the last quarter. Liberty Wealth Management LLC grew its holdings in shares of CVS Health by 108.9% during the 3rd quarter. Liberty Wealth Management LLC now owns 631 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 329 shares in the last quarter. Dimension Capital Management LLC purchased a new position in shares of CVS Health during the 3rd quarter valued at $47,000. Finally, Advisory Alpha LLC purchased a new position in shares of CVS Health during the 3rd quarter valued at $48,000. Institutional investors and hedge funds own 74.21% of the company’s stock.

A number of equities research analysts recently issued reports on CVS shares. Piper Sandler upped their price objective on shares of CVS Health from $72.00 to $76.00 and gave the stock an “overweight” rating in a report on Wednesday, November 11th. BidaskClub upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 7th. Jefferies Financial Group upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $90.00 price objective for the company in a report on Friday, January 8th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Monday, November 9th. Finally, SVB Leerink boosted their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “market perform” rating in a research report on Monday, December 14th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $82.93.

In related news, EVP Alan Lotvin sold 25,836 shares of the company’s stock in a transaction dated Friday, January 8th. The shares were sold at an average price of $75.00, for a total value of $1,937,700.00. Following the sale, the executive vice president now owns 18,469 shares of the company’s stock, valued at $1,385,175. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Lisa Bisaccia sold 25,177 shares of the company’s stock in a transaction dated Tuesday, January 12th. The shares were sold at an average price of $77.00, for a total transaction of $1,938,629.00. Following the completion of the sale, the executive vice president now directly owns 71,765 shares in the company, valued at approximately $5,525,905. The disclosure for this sale can be found here. Insiders have sold 58,151 shares of company stock valued at $4,375,989 in the last ninety days. 0.46% of the stock is owned by company insiders.

Shares of CVS traded down $1.34 during trading hours on Wednesday, reaching $74.92. 6,149,621 shares of the company traded hands, compared to its average volume of 8,405,203. The stock’s fifty day moving average is $70.55 and its 200 day moving average is $64.33. The stock has a market cap of $98.06 billion, a P/E ratio of 12.38, a price-to-earnings-growth ratio of 1.69 and a beta of 0.82. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.67 and a current ratio of 0.95. CVS Health Co. has a 1-year low of $52.04 and a 1-year high of $77.23.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 11th. The pharmacy operator reported $1.66 EPS for the quarter, beating the Zacks’ consensus estimate of $1.33 by $0.33. The business had revenue of $67.05 billion during the quarter, compared to analyst estimates of $66.54 billion. CVS Health had a net margin of 2.99% and a return on equity of 15.60%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.84 earnings per share. On average, equities research analysts predict that CVS Health Co. will post 7.43 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 1st. Stockholders of record on Friday, January 22nd will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date of this dividend is Thursday, January 21st. CVS Health’s dividend payout ratio is currently 28.25%.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services.

Recommended Story: Beta

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.